Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
Completed
120 enrolled
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
Completed
119 enrolled
Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer
Completed
266 enrolled
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Phase 2 Completed
40 enrolled
PLATON
Phase NA Completed
400 enrolled
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Phase 1 Completed
9 enrolled
HPD_single
Completed
50 enrolled
FANCY
Completed
17,380 enrolled
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Phase 1 Completed
46 enrolled
Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder Cancer
Completed
37 enrolled
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
Phase 1 Completed
17 enrolled
ASPIRE
Phase NA Completed
340 enrolled
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
Phase 2 Completed
28 enrolled 20 charts
TAS-102 in Treating Advanced Biliary Tract Cancers
Phase 2 Completed
28 enrolled 12 charts
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery
Phase 2 Completed
61 enrolled 9 charts
IMMUCHEC
Phase 2 Completed
128 enrolled
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1 Completed
50 enrolled
ABC-08
Phase 1 Completed
21 enrolled
PRO-YOU
Phase NA Completed
44 enrolled 28 charts
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report
Completed
1 enrolled
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers
Phase 2 Completed
62 enrolled 10 charts
Single Agent Regorafenib in Refractory Advanced Biliary Cancers
Phase 2 Completed
39 enrolled 11 charts
IRE
Phase NA Completed
30 enrolled
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
Phase 2 Completed
24 enrolled 11 charts
TreeTopp
Phase 2/3 Completed
151 enrolled 18 charts
Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer
Phase 2 Completed
62 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Phase 1 Completed
79 enrolled
ABC06
Phase 3 Completed
162 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Phase 2 Completed
43 enrolled 15 charts
Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction
Phase NA Completed
72 enrolled
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase 1 Completed
28 enrolled
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Completed
115 enrolled
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase 1 Completed
7 enrolled
A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
Phase 2 Completed
50 enrolled 12 charts
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery
Phase 3 Completed
190 enrolled
Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas
Phase 2 Completed
37 enrolled
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase 2 Completed
42 enrolled
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
Phase 2 Completed
40 enrolled
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
Phase 2/3 Completed
34 enrolled
ABC-04
Phase 1 Completed
13 enrolled
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Completed
98 enrolled
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
Phase 2 Completed
39 enrolled 7 charts
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer
Phase 1 Completed
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Phase 1 Completed
33 enrolled
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
Phase 1 Completed
16 enrolled
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
Phase 2 Completed
50 enrolled 21 charts